[1]
2021. Rapid and sustained improvements in itch and sleep with tralokinumab treatment in patients with moderate-to-severe Atopic Dermatitis, a post hoc analysis of pooled data from ECZTRA 1 and 2. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s61. DOI:https://doi.org/10.25251/skin.5.supp.61.